Skip to main content

Synthesis and Vaccine Evaluation of the Tumor Associated Carbohydrate Antigen RM2 from Prostate Cancer

  • Book
  • © 2015

Overview

  • Nominated by National Taiwan University as an outstanding Ph.D. thesis
  • Introduces the synthesis of RM2 antigen using the [1+2+3] one-pot sequential strategy
  • Presents the preparation of vaccine candidates and the results of vaccination studies
  • Includes total synthesis of a-(2 ? 3)/ a-(2 ? 6)-disialyl ganglioside derivatives as cancer-associated antigens
  • Includes supplementary material: sn.pub/extras

Part of the book series: Springer Theses (Springer Theses)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 16.99 USD 39.99
Discount applied Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (4 chapters)

Keywords

About this book

This thesis focuses on the synthesis and vaccine evaluation of the prostate tumor- associated carbohydrate antigen RM2. The author first presents the use of the [1+2+3] one-pot sequential strategy to successfully synthesise the RM2 antigen and its analogues as single stereoisomers in every glycosylation step, producing good yields and stereoselectivity. He then introduces the conjugation of the synthetic RM2 antigen to the carrier protein CRM197 in an average number of 1–10 to create the prostate cancer vaccine candidate, which is combined with α-galactosylceramide C1, its analogue C34, or Alu. The results of the vaccination studies in mice are also described and indicate that the strongest anti-RM2 antigen titer is exhibited when one molecule of diphtheria toxin (DT) is conjugated with an average of 4.7 molecules of RM2 antigen (DT-RM4.7) and adjuvanted with the glycolipid C34. More importantly, the induced mouse antibodies mediate the effective complement-dependent cytotoxicity (CDC) against the prostate cancer cell line LNCap. The study presented in this thesis is the first ever to successfully synthesize this complex glycan molecule. Owing to the steric hindrance of the adjacent sialyl moiety, the introduction of two sialic acid units to the compact and rigid 3,4 di branched galactoside unit is very challenging and the β-selective and efficient glycosylation of the galactosamine moiety at the 4-position of di branched galactose is also problematic.

Authors and Affiliations

  • Department of Chemistry, National Taiwan University, Taipei, Taiwan

    Hong-Yang Chuang

Bibliographic Information

  • Book Title: Synthesis and Vaccine Evaluation of the Tumor Associated Carbohydrate Antigen RM2 from Prostate Cancer

  • Authors: Hong-Yang Chuang

  • Series Title: Springer Theses

  • DOI: https://doi.org/10.1007/978-3-662-46848-7

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Chemistry and Materials Science, Chemistry and Material Science (R0)

  • Copyright Information: Springer-Verlag Berlin Heidelberg 2015

  • Hardcover ISBN: 978-3-662-46847-0Published: 05 May 2015

  • Softcover ISBN: 978-3-662-52634-7Published: 29 October 2016

  • eBook ISBN: 978-3-662-46848-7Published: 23 April 2015

  • Series ISSN: 2190-5053

  • Series E-ISSN: 2190-5061

  • Edition Number: 1

  • Number of Pages: XIII, 108

  • Number of Illustrations: 41 b/w illustrations, 26 illustrations in colour

  • Topics: Carbohydrate Chemistry, Vaccine, Immunology, Medicinal Chemistry

Publish with us